Rank;Global Rank;Institution;Country;Sector
1;126;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
2;134;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
3;221;AstraZeneca, United Kingdom;GBR;Companies
4;233;Siemens AG, Germany;DEU;Companies
5;254;BMJ Group;GBR;Companies
6;260;Hoffmann-La Roche Ltd, Switzerland;CHE;Companies
7;283;Merck KGaA, Germany;DEU;Companies
8;309;GlaxoSmithKline, United Kingdom;GBR;Companies
9;312;Novo Nordisk A/S;DNK;Companies
10;321;Janssen Research & Development, LLC;BEL;Companies
11;332;Boehringer Ingelheim GmbH Germany;DEU;Companies
12;338;Bayer AG, Germany;DEU;Companies
13;392;Philips Research, Eindhoven;NLD;Companies
14;406;Novartis, Switzerland;CHE;Companies
14;406;VTT Technical Research Centre of Finland;FIN;Companies
16;441;AstraZeneca, Sweden;SWE;Companies
17;442;GlaxoSmithKline, Belgium;BEL;Companies
18;451;Danone Nederland BV;NLD;Companies
19;456;BASF, Germany;DEU;Companies
20;457;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
21;494;Nestle Switzerland;CHE;Companies
22;520;Pfizer Inc, United Kingdom;GBR;Companies
23;531;UCB Pharma SA, Brussels;BEL;Companies
24;555;SINTEF Group;NOR;Companies
25;597;Eli Lilly and Company Ltd., United Kingdom;GBR;Companies
26;630;IMEC International;BEL;Companies
27;701;Elsevier, France;FRA;Companies